Alex N. Bullock

12.7k total citations · 3 hit papers
108 papers, 8.7k citations indexed

About

Alex N. Bullock is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alex N. Bullock has authored 108 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 41 papers in Oncology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alex N. Bullock's work include Ubiquitin and proteasome pathways (19 papers), Heterotopic Ossification and Related Conditions (17 papers) and Cancer-related Molecular Pathways (17 papers). Alex N. Bullock is often cited by papers focused on Ubiquitin and proteasome pathways (19 papers), Heterotopic Ossification and Related Conditions (17 papers) and Cancer-related Molecular Pathways (17 papers). Alex N. Bullock collaborates with scholars based in United Kingdom, United States and Germany. Alex N. Bullock's co-authors include Stefan Knapp, Alan R. Fersht, Peter Canning, J.E. Debreczeni, F.J. Sorrell, Matthieu Schapira, Craig M. Crews, Matthew F. Calabrese, Alan R. Fersht and A. Chaikuad and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Alex N. Bullock

107 papers receiving 8.5k citations

Hit Papers

Targeted protein degrada... 2002 2026 2010 2018 2019 2002 2015 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeted protein degradation: expanding the toolbox
    2019 642 citations Alex N. Bullock et al. profile →
  2. Hypoxia-inducible Factor (HIF) Asparagine Hydroxylase Is Identical to Factor Inhibiting HIF (FIH) and Is Related to the Cupin Structural Family
    2002 602 citations Alex N. Bullock, Peter J. Ratcliffe et al. Journal of Biological Chemistry profile →
  3. Structural basis of Keap1 interactions with Nrf2
    2015 475 citations Alex N. Bullock et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex N. Bullock United Kingdom 49 6.1k 2.8k 1.1k 872 802 108 8.7k
Aviv Gazit Israel 45 5.3k 0.9× 3.3k 1.2× 913 0.9× 1.1k 1.2× 550 0.7× 99 9.7k
Pascal Furet Switzerland 50 5.6k 0.9× 2.4k 0.8× 602 0.6× 2.0k 2.3× 512 0.6× 125 8.6k
Peter Atadja United States 58 9.5k 1.6× 2.6k 0.9× 910 0.9× 470 0.5× 425 0.5× 150 11.2k
Lyubomir T. Vassilev United States 36 7.0k 1.2× 5.0k 1.8× 1.1k 1.0× 887 1.0× 434 0.5× 70 9.3k
Gideon Bollag United States 51 10.1k 1.7× 4.6k 1.7× 1.1k 1.1× 841 1.0× 1.5k 1.8× 124 14.7k
Cristiano Ferlini Italy 41 3.0k 0.5× 1.7k 0.6× 1.0k 1.0× 512 0.6× 481 0.6× 136 5.3k
Adrian M. Senderowicz United States 45 4.9k 0.8× 3.8k 1.4× 763 0.7× 602 0.7× 709 0.9× 110 8.1k
Amancio Carnero Spain 47 6.2k 1.0× 2.9k 1.0× 2.2k 2.1× 504 0.6× 826 1.0× 209 9.6k
Qing‐Bai She United States 33 5.0k 0.8× 1.8k 0.6× 999 0.9× 288 0.3× 786 1.0× 73 6.6k
Klaus Podar United States 63 8.7k 1.4× 4.6k 1.6× 1.3k 1.2× 398 0.5× 1.3k 1.6× 186 12.8k

Countries citing papers authored by Alex N. Bullock

Since Specialization
Citations

This map shows the geographic impact of Alex N. Bullock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex N. Bullock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex N. Bullock more than expected).

Fields of papers citing papers by Alex N. Bullock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex N. Bullock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex N. Bullock. The network helps show where Alex N. Bullock may publish in the future.

Co-authorship network of co-authors of Alex N. Bullock

This figure shows the co-authorship network connecting the top 25 collaborators of Alex N. Bullock. A scholar is included among the top collaborators of Alex N. Bullock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex N. Bullock. Alex N. Bullock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wong, Jong Fu, Carlos Zepeda‐Velázquez, Laurent Hoffer, et al.. (2024). Discovery of Conformationally Constrained ALK2 Inhibitors. Journal of Medicinal Chemistry. 67(6). 4707–4725. 3 indexed citations
2.
Miller, Kerry A., David A. Cruz Walma, Daniel M. Pinkas, et al.. (2024). BTB domain mutations perturbing KCTD15 oligomerisation cause a distinctive frontonasal dysplasia syndrome. Journal of Medical Genetics. 61(5). 490–501. 5 indexed citations
3.
Ong, Han Wee, William Richardson, Emily R. Lowry, et al.. (2023). Discovery of a Potent and Selective CDKL5/GSK3 Chemical Probe That Is Neuroprotective. ACS Chemical Neuroscience. 14(9). 1672–1685. 7 indexed citations
4.
5.
Chen, Zhuoyao, Stacey Richardson, Iolanda Vendrell, et al.. (2022). Disease-associated KBTBD4 mutations in medulloblastoma elicit neomorphic ubiquitylation activity to promote CoREST degradation. Cell Death and Differentiation. 29(10). 1955–1969. 17 indexed citations
6.
Berger, Benedict‐Tilman, Martin Schröder, Deep Chatterjee, et al.. (2021). Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical Probe. Journal of Medicinal Chemistry. 64(18). 13451–13474. 5 indexed citations
7.
Smil, David, Carlos Zepeda‐Velázquez, Dimitrios Panagopoulos, et al.. (2020). Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma. Journal of Medicinal Chemistry. 63(9). 4978–4996. 15 indexed citations
8.
Sánchez‐Duffhues, Gonzalo, Eleanor Williams, Valeria V. Orlova, et al.. (2019). Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva‐Derived Endothelial Cells. JBMR Plus. 3(11). e10230–e10230. 23 indexed citations
9.
Zhu, Dongsheng, Huocong Huang, Daniel M. Pinkas, et al.. (2019). 2-Amino-2,3-dihydro-1H-indene-5-carboxamide-Based Discoidin Domain Receptor 1 (DDR1) Inhibitors: Design, Synthesis, and in Vivo Antipancreatic Cancer Efficacy. Journal of Medicinal Chemistry. 62(16). 7431–7444. 54 indexed citations
10.
Hrdinka, Matouš, Lisa Schlicher, Bing Dai, et al.. (2018). Small molecule inhibitors reveal an indispensable scaffolding role of RIPK 2 in NOD 2 signaling. The EMBO Journal. 37(17). 48 indexed citations
11.
Miller, Kerry A., et al.. (2018). A dominant-negative mutation in the BTB domain of KCTD15 in a family with frontal lipoma, congenital heart disease and cutis aplasia of the scalp defines a novel syndrome. European Journal of Human Genetics. 26. 233–234. 1 indexed citations
12.
Fulcher, Luke J., Polyxeni Bozatzi, Kevin Z. L. Wu, et al.. (2018). The DUF1669 domain of FAM83 family proteins anchor casein kinase 1 isoforms. Science Signaling. 11(531). 87 indexed citations
13.
14.
Wang, Zhen, Yali Zhang, Sergio G. Bartual, et al.. (2017). Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors. ACS Medicinal Chemistry Letters. 8(3). 327–332. 35 indexed citations
15.
Horbelt, Daniel, Jan H. Boergermann, A. Chaikuad, et al.. (2014). Small Molecules Dorsomorphin and LDN-193189 Inhibit Myostatin/GDF8 Signaling and Promote Functional Myoblast Differentiation. Journal of Biological Chemistry. 290(6). 3390–3404. 46 indexed citations
16.
Quigley, Andrew, Yin Yao Dong, A.C.W. Pike, et al.. (2013). The Structural Basis of ZMPSTE24-Dependent Laminopathies. Science. 339(6127). 1604–1607. 79 indexed citations
17.
Zadjali, Fahad, A.C.W. Pike, Mattias Vesterlund, et al.. (2010). Structural Basis for c-KIT Inhibition by the Suppressor of Cytokine Signaling 6 (SOCS6) Ubiquitin Ligase. Journal of Biological Chemistry. 286(1). 480–490. 57 indexed citations
18.
Bullock, Alex N., J.E. Debreczeni, P. Rellos, et al.. (2009). Kinase Domain Insertions Define Distinct Roles of CLK Kinases in SR Protein Phosphorylation. Structure. 17(3). 352–362. 92 indexed citations
19.
Grosfeld, Alexandra, Ineke Stolze, Matthew E. Cockman, et al.. (2007). Interaction of Hydroxylated Collagen IV with the von Hippel-Lindau Tumor Suppressor. Journal of Biological Chemistry. 282(18). 13264–13269. 56 indexed citations
20.
Pogačić, Vanda, Alex N. Bullock, O. Fedorov, et al.. (2007). Structural Analysis Identifies Imidazo[1,2- b ]Pyridazines as PIM Kinase Inhibitors with In vitro Antileukemic Activity. Cancer Research. 67(14). 6916–6924. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aviv Gazit Breakdown of academic impact, for papers by Pascal Furet Breakdown of academic impact, for papers by Peter Atadja Breakdown of academic impact, for papers by Lyubomir T. Vassilev Breakdown of academic impact, for papers by Gideon Bollag Breakdown of academic impact, for papers by Cristiano Ferlini Breakdown of academic impact, for papers by Adrian M. Senderowicz Breakdown of academic impact, for papers by Amancio Carnero Breakdown of academic impact, for papers by Qing‐Bai She Breakdown of academic impact, for papers by Klaus Podar
Rankless by CCL
2026